about
Eicosanoids Derived From Arachidonic Acid and Their Family Prostaglandins and Cyclooxygenase in Psychiatric DisordersMitochondrial Dysfunction and Its Relationship with mTOR Signaling and Oxidative Damage in Autism Spectrum Disorders.Editorial. New Targets of Medical Treatment in Psychiatric Disorders.Reduced endogenous urinary total antioxidant power and its relation of plasma antioxidant activity of superoxide dismutase in individuals with autism spectrum disorder.Psycho-Cognitive Intervention for ASD from Cross-Species Behavioral Analyses of Infants, Chicks and Common Marmosets.Oxidative Stress and Nitric Oxide in Autism Spectrum Disorder and Other Neuropsychiatric Disorders.Decreased total antioxidant capacity has a larger effect size than increased oxidant levels in urine in individuals with autism spectrum disorder.A cross-species socio-emotional behaviour development revealed by a multivariate analysis.Increased ω-3 polyunsaturated fatty acid/arachidonic acid ratios and upregulation of signaling mediator in individuals with autism spectrum disorders.Competitive Interaction Between Plasma Omega-3 Fatty Acids and Arachidonic Acid is Related to Down-Regulation of A Signaling Mediator.Mitochondrial Dysfunction and Its Relation to Translocator Protein, Oxidative Stress, mTOR Signaling, and Synaptic Protein.Down-regulation of a signaling mediator in association with lowered plasma arachidonic acid levels in individuals with autism spectrum disorders.Preface: Recent advances of neurobiological basis of stimulant-induced sensitizationIncreased sensitivity to stress associated with noradrenergic hyperactivity, involving dopaminergic hyperactivity in spontaneous recurrences in methamphetamine psychosisImprovement in Impaired Social Cognition but Not Seizures by Everolimus in a Child with Tuberous Sclerosis-Associated Autism through Increased Serum Antioxidant Proteins and Oxidant/Antioxidant Status
P50
Q36594940-6B08E7F1-A0A8-4987-A97F-058BE4AE4046Q38440971-E9E829B4-43D2-4149-81C3-E9FD7ACB58FAQ38553202-944F261C-B206-4701-B663-79C6887768E2Q39460895-9549007A-AFA7-4026-810B-742963A2215DQ39856262-24C44C70-7286-4F7E-95AD-8AE4FFB94174Q46564658-22DE981F-2542-4543-97B3-EE9530D00E2FQ47232269-81D8119A-2B96-4D61-A0EF-32D45B5F0275Q47980733-4A35AF4F-E8F6-46D3-BE68-D8D620A8F3EBQ49060157-D127692B-6FE7-4E7A-AED1-E3D6B5A1C911Q50307280-69E445C4-80D0-40E9-AEE8-215AF76B22FEQ50311846-1DA6621F-2886-4F48-88F2-3A6D33CB1DE3Q50341121-BC0F8AF0-46F1-48F6-914D-51E2747F9B29Q84471621-2BEBA332-E20C-4C0A-927A-83F338C36E01Q84471631-2BCC54DC-EB83-4BC4-8B1D-31B14747AA5FQ92221800-64292A54-F767-471B-B7C6-FBD33D4DB04C
P50
description
investigador
@es
researcher
@en
name
K Yui
@en
type
label
K Yui
@en
prefLabel
K Yui
@en
P31
P496
0000-0002-3714-2956